Evidence map›Paper›PMID 39822075›Full record

ArticleAnnals of medicine2025

Changes in the effective optical zone following hyperopic keratorefractive lenticule extraction.

Yangyi Huang, Dan Fu, Yuliang Wang, Xiaoliao Peng, Tian Han, Xingtao Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yangyi HuangEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-7169-1596
Dan FuEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Yuliang WangEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Xiaoliao PengEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Tian HanEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Xingtao ZhouEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-3465-1579

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the longitudinal changes in the effective optical zone (EOZ) following hyperopic keratorefractive lenticule extraction (KLEx) and investigate factors influencing the EOZ. PATIENTS AND

methodsThis retrospective study included 27 patients who underwent hyperopic KLEx. According to the transition zone (TZ) sizes, they were divided into two groups: group A (21 eyes) with a 2.0-mm TZ and group B (10 eyes) with a 0 or 0.2-mm TZ. The programmed treatment zone (PTZ) was the sum of the programmed optical zone (POZ) and the TZ.. Changes in the EOZ were evaluated at the early (within 1 month postoperatively) and late (over 6 months postoperatively) postoperative stages. The effects of the surgical and corneal topographic parameters on EOZ were explored.

resultsA significantly higher postoperative spherical equivalent was found in group B than in group A (

conclusionsThe EOZ continued decreasing following hyperopic KLEx. A larger TZ and POZ would result in a larger postoperative EOZ.

Indexed as

HyperopiaAdultCorneal TopographyFemaleHumansMalePostoperative PeriodRefraction, OcularRetrospective StudiesTreatment OutcomeVisual AcuityYoung Adulteffective optical zonehyperopiaKeratorefractive lenticule extraction (KLEx)transition zone

Identifiers

PMID39822075
PMCPMC11749147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.